Telah dikemas kini
HAPP has interesting prospects
In looking at Happiness Biotech Group, I see some potential.
From TOS analysis
- Price/Book .5231
- P/E 6.67
- Free Cash Flow per Share $.52
If Happiness Biotech could return $.52 for the next 3 years, it would essentially generate almost enough free cash flow to cover the cost of stock at $1.74 per share. I really don't think that this stock could get much cheaper in a rational market. Additionally, it looks like the support level is about $1.69 per share which may be a good entry point if it hits that level.
Additionally, they had some good news with a launch of their cross-border ecommerce platform and record sales in March of $14M.
Not investment advice, just my perspective.
From TOS analysis
- Price/Book .5231
- P/E 6.67
- Free Cash Flow per Share $.52
If Happiness Biotech could return $.52 for the next 3 years, it would essentially generate almost enough free cash flow to cover the cost of stock at $1.74 per share. I really don't think that this stock could get much cheaper in a rational market. Additionally, it looks like the support level is about $1.69 per share which may be a good entry point if it hits that level.
Additionally, they had some good news with a launch of their cross-border ecommerce platform and record sales in March of $14M.
Not investment advice, just my perspective.
Nota
This one has been a panful lesson. I still hold a position in this company, but it never seemed to materialize
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.